日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events

细胞粘附于内皮细胞会加剧 Blinatumomab 相关的神经系统不良事件

Matthias Klinger #, Gerhard Zugmaier #, Virginie Nägele, Maria-Elisabeth Goebeler, Christian Brandl, Matthias Stelljes, Hans Lassmann, Arend von Stackelberg, Ralf C Bargou #, Peter Kufer #

Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs

针对 HIV gp120 的双特异性 T 细胞衔接抗体构建体的抗病毒活性

Johannes Brozy # ,Erika Schlaepfer # ,Christina K S Mueller ,Mary-Aude Rochat ,Silvana K Rampini ,Renier Myburgh ,Tobias Raum ,Peter Kufer ,Patrick A Baeuerle ,Markus Muenz # ,Roberto F Speck #

Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma

非霍奇金淋巴瘤患者中 Blinatumomab 的药代动力学和药效学关系

Youssef Hijazi, Matthias Klinger, Andrea Kratzer, Benjamin Wu, Patrick A Baeuerle, Peter Kufer, Andreas Wolf, Dirk Nagorsen, Min Zhu

Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL

复发/难治性 ALL 患者接受 Blinatumomab 治疗后临床实验室参数和药效学标志物的变化

Virginie Nägele #, Andrea Kratzer #, Gerhard Zugmaier, Chris Holland, Youssef Hijazi, Max S Topp, Nicola Gökbuget, Patrick A Baeuerle, Peter Kufer, Andreas Wolf, Matthias Klinger

Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110

癌细胞的多种免疫逃避机制对 EpCAM/CD3-双特异性抗体构建体 AMG 110 所结合的 T 细胞的影响

Wibke Deisting, Tobias Raum, Peter Kufer, Patrick A Baeuerle, Markus Münz

Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies

五种经过临床测试的抗 EpCAM 单克隆抗体的并行分析

Markus Münz, Alexander Murr, Majk Kvesic, Doris Rau, Susanne Mangold, Stefan Pflanz, John Lumsden, Jörg Volkland, Jan Fagerberg, Gert Riethmüller, Dominik Rüttinger, Peter Kufer, Patrick A Baeuerle, Tobias Raum

Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cells

通过与人类 T 细胞结合的 EpCAM/CD3 双特异性抗体高效消除结直肠肿瘤起始细胞

Ines Herrmann, Patrick A Baeuerle, Matthias Friedrich, Alexander Murr, Susanne Filusch, Dominik Rüttinger, Mariam W Majdoub, Sherven Sharma, Peter Kufer, Tobias Raum, Markus Münz

Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans

小鼠中 EpCAM/CD3 特异性 BiTE 抗体的治疗窗口由人类中不存在的 EpCAM 表达淋巴细胞亚群决定

Maria Amann, Matthias Friedrich, Petra Lutterbuese, Eva Vieser, Grit Lorenczewski, Laetitia Petersen, Klaus Brischwein, Peter Kufer, Roman Kischel, Patrick A Baeuerle, Bernd Schlereth

Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells

人类 IgG1 抗体拮抗自然杀伤细胞上的激活受体 NKG2D

Jutta Steigerwald, Tobias Raum, Stefan Pflanz, Ronny Cierpka, Susanne Mangold, Doris Rau, Patrick Hoffmann, Majk Kvesic, Christina Zube, Stefanie Linnerbauer, John Lumsden, Mirnaalini Sriskandarajah, Peter Kufer, Patrick A Baeuerle, Jörg Volkland

The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct

地塞米松对 CD19/CD3 双特异性单链抗体构建体诱导的多克隆 T 细胞活化和重定向靶细胞裂解的影响

Christian Brandl, Cornelia Haas, Sandrine d'Argouges, Tanja Fisch, Peter Kufer, Klaus Brischwein, Nadja Prang, Ralf Bargou, JoAnn Suzich, Patrick A Baeuerle, Robert Hofmeister